Orlando Business Assistance Program
City of Orlando
About the Grant
The Business Assistance Program (BAP) is a matching grant program designed to encourage small businesses to locate, expand or redevelop in the City of Orlando.
BAP provides matching funds to new and expanding businesses in the city to assist in off-setting development fees, including sewer and transportation impact fees, building permit fees, and all elements of public right-of-way infrastructure within the city’s jurisdiction that may require new installation, repair, replacement or relocation.
Eligible improvements include, but are not limited to, street lighting and fire hydrant installation/relocation, sidewalk repairs; traffic signalization; water and sewer line construction, removal or relocation; curb, gutter, street improvements and landscaping or installation of publicly accessible electric vehicle (EV) charging infrastructure.
The Economic Development Department administers and monitors the program, as well as determines eligibility of applicants.
The program requires eligible business owners to pay 50 percent of the fees assessed against the business, while the program fund pays the remaining 50 percent up to $20,000.
Notes
Related Grants
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to identify new druggable targets for pain within the understudied druggable proteome. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s) listed in this NOFO. This NOFO is intended to jumpstart research on understudied proteins within the context of pain and pain management and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins to identify new druggable targets for pain. This NOFO is part of the NIH Helping to End Addiction Long Term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progression to chronic use, withdrawal symptoms, craving, relapse, and overdose.
UT Economic Assistance Grant
UT Office of Economic Opportunity
The Economic Assistance Grant program promotes economic development in Utah through business grants focused on industry, education, community development, and infrastructure. This grant is for one-time, project-based awards up to $200,000.
RI Non-Trade Apprenticeship Expansion Grants
Rhode Island Commerce Corporation
The Non-Trade Apprenticeship Expansion Grant Program was created to support the expansion of Non-Trade/Non-Traditional Registered Apprenticeship Programs. The program helps organizations pay for the design and development of new and innovative apprenticeship tracks by providing reimbursement for eligible planning activities and costs up to $25,000.
CFDA x NY Forward Grant Fund
Council of Fashion Designers of America
The CFDA x NY Forward Grant Fund, created in partnership with the New York State Department of State, is dedicated to sustaining the New York City Garment District, the historic heart of American fashion production. The program will provide grants to New York City Garment District-based fashion manufacturers as well as designers producing in-house. Two rounds of funding will be distributed, one in 2026 and another in 2027, empowering businesses to invest in innovation, expand production capacity, and preserve local jobs, contributing to the revitalization of this commercial hub. In each round, one manufacturer recipient will also receive the Ralph Lauren Manufacturing Award, providing the full grant amount in recognition of the most innovative approach to advancing their business.
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes
National Institutes of Health
This notice of funding opportunity (NOFO) invites applications designed to examine the efficacy and clinical effectiveness of multimodality digital health technology approaches to the remote management of diabetes.